K-237
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for K-237, covering 2024-05-20 to 2024-05-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Confirmatory Study of K-237 [Phase 3]
1 regulatory and trial event tracked for K-237, covering 2024-05-20 to 2024-05-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Confirmatory Study of K-237 [Phase 3]